Morgan Stanley (MS) concluded trading on Tuesday at a closing price of $127.06, with 2.9 million shares of worth about $368.83 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 31.27% during that period and on December 24, 2024 the price saw a gain of about 2.10%. Currently the company’s common shares owned by public are about 1.61B shares, out of which, 1.23B shares are available for trading.
Stock saw a price change of -0.43% in past 5 days and over the past one month there was a price change of -5.57%. Year-to-date (YTD), MS shares are showing a performance of 36.40% which increased to 37.64% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $83.09 but also hit the highest price of $136.24 during that period. The average intraday trading volume for Morgan Stanley shares is 6.53 million. The stock is currently trading -0.64% below its 20-day simple moving average (SMA20), while that difference is up 0.85% for SMA50 and it goes to 21.04% higher than SMA200.
Morgan Stanley (NYSE: MS) currently have 1.61B outstanding shares and institutions hold larger chunk of about 61.62% of that.
The stock has a current market capitalization of $208.99B and its 3Y-monthly beta is at 1.35. PE ratio of stock for trailing 12 months is 19.31, while it has posted earnings per share of $6.58 in the same period. Its PEG reads 1.12 while making debt-to-equity ratio of 3.78. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MS, volatility over the week remained 3.51% while standing at 2.06% over the month.
Stock’s fiscal year EPS is expected to rise by 42.00% while it is estimated to increase by 9.24% in next year. EPS is likely to grow at an annualized rate of 17.30% for next 5-years, compared to annual growth of 1.84% made by the stock over the past 5-years.
Coverage by Wells Fargo stated Morgan Stanley (MS) stock as an Equal weight in their note to investors on November 15, 2024, suggesting a price target of $142 for the stock. Stock get an Underweight rating from Wells Fargo on August 02, 2024.
